Currently, Makis Papataxiarchis is managingh director of Johnson & Johnson Romania and Janssen Romania, pharmaceutical companies. He delivers a 17-uear experience as manager in marketing and sales, in Greece and in different European countries. He spent 5 years with Novartis and 12 years at Johnson & Johnson and as well, he managed different strategic planning teams for EMEA countries.
ARPIM’s Board consist in: Regis Lhomme, Vice-president and GM of Amgen Romania; Radu Rasinar, Vice-president and GM Astra Zeneca; Elena Mitova, member and GM of Novartis; Calin Galaseanu, member and GM of BMS; Pascal Prigent, member and GM of GlaxoSmithKline; Luca Visini, member and GM of director genaral of Eli Lilly and Dan Zaharescu, executive director of ARPIM.
You can read the entire article in Romanian here.
